Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Go to Funding Search

Key Information

Due Date: November 5, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Not Specified


Match Required: No


Contact Info:

Overview

The Alzheimer's Drug Development Program is a funding opportunity that is set aside for medical research, specifically for pre-clinical and initial stage clinical trials (Phase I). The aim of this grant is to financially support the development of new drugs, both small-molecule and biologic. The fund is specifically interested in backing drug projects that focus on preventing Alzheimer's disease, slowing down its progression, or treating the cognitive and behavioral symptoms associated with the disease. Importantly, conducting a clinical trial is not a requirement to apply for this funding opportunity.
Show More

Key Dates

Open Date: Not Specified


Application Due Date: November 5, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • Unrestricted

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.